Actuate Therapeutics, Inc.
ACTU
$1.95
$0.021.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 22.74% | -22.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 21.70% | -14.32% | |||
| Operating Income | -21.70% | 14.32% | |||
| Income Before Tax | -23.53% | 15.78% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -23.53% | 15.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -23.53% | 15.78% | |||
| EBIT | -21.70% | 14.32% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -23.45% | 23.39% | |||
| Normalized Basic EPS | -23.47% | 23.42% | |||
| EPS Diluted | -23.45% | 23.39% | |||
| Normalized Diluted EPS | -23.47% | 23.42% | |||
| Average Basic Shares Outstanding | 0.04% | 9.97% | |||
| Average Diluted Shares Outstanding | 0.04% | 9.97% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||